Multiple Sclerosis

Multiple Sclerosis Clinical Trials and Drug Development History

For centuries, MS was recognized as a condition characterized by episodic and progressive neurological deterioration, classified as ‘paraplegia’

Mar 28, 2023

Multiple Sclerosis Expertise Data

MS-Timeline_

Similar posts

Expertise

Unleashing automated white matter lesion segmentation: Advancements in MS assessment. Evolving imaging techniques, revolutionizing diagnosis &...

Evie Neylon May 25, 2023

covid19initiatives

Global Data-sharing Initiative Launched To Help People With MS During...

Paulo Rodrigues Mar 31, 2020

covid19initiatives

A new article detailing how COVID-19 effects people with MS,outlining potential risks and recommendations for people with Multiple sclerosis.

Paulo Rodrigues Apr 8, 2020